Schizophrenia Formula 2113

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Schizophrenia Formula 2113
Generic name: SCHIZOPHRENIA FORMULA
Manufacturer: Professional Complementary Health Formulas
Product type: HUMAN OTC DRUG
SPL set ID: 4a0b233a-a069-47bc-a696-1bebdb172ca4
SPL ID: 54612b86-9045-4bcb-a492-081baf2b0f0e
Version: 2
Effective date: 2026-01-08
Source export date: 2026-10-12
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:44:39

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Schizophrenia Formula 2113	openfda.brand_name
generic name		SCHIZOPHRENIA FORMULA	openfda.generic_name
manufacturer name		Professional Complementary Health Formulas	openfda.manufacturer_name
ndc	package	63083-2113-2	openfda.package_ndc
ndc	product	63083-2113	openfda.product_ndc
ndc11	package	63083211302	derived:openfda.package_ndc
spl id		54612b86-9045-4bcb-a492-081baf2b0f0e	id
spl set id		4a0b233a-a069-47bc-a696-1bebdb172ca4	set_id
unii		3C18L6RJAZ	openfda.unii
unii		M6XU683549	openfda.unii
unii		BKJ0J3D1BP	openfda.unii
unii		K8F3G29S6Z	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS Persistent symptoms may be a sign of a serious condition. Consult a doctor immediately if symptoms persist or are accompanied by hallucinations or thoughts of harming self or others. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.